MED Earnings

Quarterly EPS
$0.10
Q3 2024
$0.07
Q4 2024
$-0.07
Q1 2025
$0.23
Q2 2025
$-0.21
Q3 2025
$-1.65
Q4 2025
$-0.19
Q1 2026
$-0.28
Q2 2026
Latest Revenue76.4M
Latest Net Income-3100000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.2876.4M-3100000-27.6%-221.7%
Q1 2026-$0.1976.0M-2122000-34.3%-171.4%
Q4 2025-$1.6575.1M-18119000-36.9%-2,457.1%
Q3 2025-$0.2189.4M-2261000-36.2%-310.0%
Q2 2025$0.23105.6M2.5M-37.4%+130.7%
Q1 2025-$0.07115.7M-772000-33.8%-109.2%
Q4 2024$0.07119.0M801.0K-37.7%-87.3%
Q3 2024$0.10140.2M1.1M-40.6%-95.3%
Q2 2024-$0.75168.6M-8154000
Q1 2024$0.76174.7M8.3M
Q4 2023$0.55191.0M6.0M
Q3 2023$2.12235.9M23.1M
Medifast (MED) — Earnings